Chikwe Ihekweazu

Chikwe Ihekweazu

Auto-generated profile, based on publicly available information

Chikwe Ihekweazu

Nigeria Centre for Disease Control

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
EPEskild Petersen
Eskild Petersen
IAIbrahim Abubakar
Ibrahim Abubakar
CIChikwe Ihekweazu
Chikwe Ihekweazu
DHDavid Heymann
David Heymann
FNFrancine Ntoumi
Francine Ntoumi
AZAlimuddin Zumla
Alimuddin Zumla
The identification of monkeypox in 3 separate patients in the United Kingdom in September raised media and political attention on an emerging public health threat. Nigeria, whose last confirmed case of monkeypox was in 1978, is currently experiencing an unusually large and outbreak of human monkeypox cases, a 'One Human-Environmental-Animal Health' approach is being effectively used to define and tackle the outbreak. As of 13th October 2018, there have been one hundred and sixteen confirmed cases the majority of whom are under 40 years. Over the past 20 years ten Central and West African countries have reported monkeypox cases which have risen exponentially. We review the history and evolution of monkeypox outbreaks in Africa and USA, the changing clinical presentations, and discuss possible factors underlying the increasing numbers being detected including the cessation of smallpox vaccination programs. Major knowledge gaps remain on the epidemiology, host reservoir, and emergence, transmission, pathogenesis and prevention of monkeypoz.

19 September 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
KEKelly Elimian
Kelly Elimian
SYSebastian Yennan
Sebastian Yennan
AMAnwar Musah
Anwar Musah
ICIliya Danladi Cheshi
Iliya Danladi Cheshi
CKCarina King
Carina King
IAIfedayo Adetifa
Ifedayo Adetifa
Objectives Nigeria reported an upsurge in cholera cases in October 2020, which then transitioned into a large, disseminated epidemic for most of 2021. This study aimed to describe the epidemiology, diagnostic performance of rapid diagnostic test (RDT) kits and the factors associated with mortality during the epidemic. Design A retrospective analysis of national surveillance data. Setting 33 of 37 states (including the Federal Capital Territory) in Nigeria. Participants Persons who met cholera case definition (a person of any age with acute watery diarrhoea, with or without vomiting) between October 2020 and October 2021 within the Nigeria Centre for Disease Control surveillance data. Outcome measures Attack rate (AR; per 100 000 persons), case fatality rate (CFR; %) and accuracy of RDT performance compared with culture using area under the receiver operating characteristic curve (AUROC). Additionally, individual factors associated with cholera deaths and hospitalisation were presented as adjusted OR with 95% CIs. Results Overall, 93 598 cholera cases and 3298 deaths (CFR: 3.5%) were reported across 33 of 37 states in Nigeria within the study period. The proportions of cholera cases were higher in men aged 5–14 years and women aged 25–44 years. The overall AR was 46.5 per 100 000 persons. The North-West region recorded the highest AR with 102 per 100 000. Older age, male gender, residency in the North-Central region and severe dehydration significantly increased the odds of cholera deaths. The cholera RDT had excellent diagnostic accuracy (AUROC=0.91; 95% CI 0.87 to 0.96). Conclusions Cholera remains a serious public health threat in Nigeria with a high mortality rate. Thus, we recommend making RDT kits more widely accessible for improved surveillance and prompt case management across the country.

6 December 2018 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JVJay K. Varma
Jay K. Varma
JOJohn Oppong-Otoo
John Oppong-Otoo
POPascale Ondoa
Pascale Ondoa
Olga PerovicOlga Perovic
Olga Perovic
BPBenjamin J. Park
Benjamin J. Park
JNJohn N. Nkengasong
John N. Nkengasong
The African Journal of Laboratory Medicine focuses on the role of the laboratory and its professionals in the clinical and public healthcare sectors, and is specifically based on an African frame of reference.

24 April 2021 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
LALiã Bárbara Arruda
Liã Bárbara Arruda
Najmul HaiderNajmul Haider
Najmul Haider
AOAyodeji Olayemi
Ayodeji Olayemi
DSDavid Simons
David Simons
DEDeborah Ehichioya
Deborah Ehichioya
RKRichard Kock
Richard Kock
Lassa fever (LF), a zoonotic illness, represents a public health burden in West African countries where the Lassa virus (LASV) circulates among rodents. Human exposure hinges significantly on LASV ecology, which is in turn shaped by various parameters such as weather seasonality and even virus and rodent-host genetics. Furthermore, human behaviour, despite playing a key role in the zoonotic nature of the disease, critically affects either the spread or control of human-to-human transmission. Previous estimations on LF burden date from the 80s and it is unclear how the population expansion and the improvement on diagnostics and surveillance methods have affected such predictions. Although recent data have contributed to the awareness of epidemics, the real impact of LF in West African communities will only be possible with the intensification of interdisciplinary efforts in research and public health approaches. This review discusses the causes and consequences of LF from a One Health perspective, and how the application of this concept can improve the surveillance and control of this disease in West Africa.

15 March 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
RTRania A. Tohme
Rania A. Tohme
HSHeather M. Scobie
Heather M. Scobie
OOOyeladun Okunromade
Oyeladun Okunromade
TOTemitope Olaleye
Temitope Olaleye
FSFaisal Shuaib
Faisal Shuaib
CIChikwe Ihekweazu
Chikwe Ihekweazu
Serological surveys provide an objective biological measure of population immunity, and tetanus serological surveys can also assess vaccination coverage. We undertook a national assessment of immunity to tetanus and diphtheria among Nigerian children aged <15 years using stored specimens collected during the 2018 Nigeria HIV/AIDS Indicator and Impact Survey, a national cross-sectional household-based survey. We used a validated multiplex bead assay to test for tetanus and diphtheria toxoid-antibodies. In total, 31,456 specimens were tested. Overall, 70.9% and 84.3% of children aged <15 years had at least minimal seroprotection (≥0.01 IU/mL) against tetanus and diphtheria, respectively. Seroprotection was lowest in the north west and north east zones. Factors associated with increased tetanus seroprotection included living in the southern geopolitical zones, urban residence, and higher wealth quintiles (p < 0.001). Full seroprotection (≥0.1 IU/mL) was the same for tetanus (42.2%) and diphtheria (41.7%), while long-term seroprotection (≥1 IU/mL) was 15.1% for tetanus and 6.0% for diphtheria. Full- and long-term seroprotection were higher in boys compared to girls (p < 0.001). Achieving high infant vaccination coverage by targeting specific geographic areas and socio-economic groups and introducing tetanus and diphtheria booster doses in childhood and adolescence are needed to achieve lifelong protection against tetanus and diphtheria and prevent maternal and neonatal tetanus.

22 March 2024 in The Lancet Global Health
Verified
Journal Article
Open access
Henry Kyobe BosaHenry Kyobe Bosa
Henry Kyobe Bosa
NKNeema Kamara
Neema Kamara
MAMerawi Aragaw
Merawi Aragaw
MWMisaki Wayengera
Misaki Wayengera
ATAmbrose Talisuna
Ambrose Talisuna
JAJane Ruth Aceng
Jane Ruth Aceng